![Figure 2 from Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma | Semantic Scholar Figure 2 from Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d23de430239326affb9e0ad4d2a1d22e050493f0/5-Figure2-1.png)
Figure 2 from Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma | Semantic Scholar
![Diffuse Large B-cell Lymphoma: Symptoms, Treatment and Prognosis: 9781634844024: Medicine & Health Science Books @ Amazon.com Diffuse Large B-cell Lymphoma: Symptoms, Treatment and Prognosis: 9781634844024: Medicine & Health Science Books @ Amazon.com](https://m.media-amazon.com/images/I/41ytfYyRPgL._AC_SY780_.jpg)
Diffuse Large B-cell Lymphoma: Symptoms, Treatment and Prognosis: 9781634844024: Medicine & Health Science Books @ Amazon.com
![Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab](https://www.mdpi.com/cancers/cancers-14-01917/article_deploy/html/images/cancers-14-01917-g001.png)
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
![Algorithm for decision-making for patients with diffuse large B-cell... | Download Scientific Diagram Algorithm for decision-making for patients with diffuse large B-cell... | Download Scientific Diagram](https://www.researchgate.net/publication/325949897/figure/fig2/AS:641626280062987@1529987034201/Algorithm-for-decision-making-for-patients-with-diffuse-large-B-cell-lymphoma.png)
Algorithm for decision-making for patients with diffuse large B-cell... | Download Scientific Diagram
![Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram](https://www.researchgate.net/publication/330523075/figure/fig5/AS:717559355682821@1548090890581/Overall-survival-of-patients-with-diffuse-large-B-cell-lymphoma-after-rituximab.png)
Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram
![Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology](https://www.thelancet.com/cms/attachment/40d2627f-634d-4227-ae9e-a73e411ae285/gr1.gif)
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology
![Course of therapy, responses and outcomes. DLBCL, diffuse large B-cell... | Download Scientific Diagram Course of therapy, responses and outcomes. DLBCL, diffuse large B-cell... | Download Scientific Diagram](https://www.researchgate.net/profile/Paul-Maciocia/publication/287483095/figure/fig2/AS:329978152538112@1455684330191/Course-of-therapy-responses-and-outcomes-DLBCL-diffuse-large-B-cell-lymphoma-CR.png)
Course of therapy, responses and outcomes. DLBCL, diffuse large B-cell... | Download Scientific Diagram
![Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options - ScienceDirect Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419369364-gr1.jpg)
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options - ScienceDirect
![Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma | Immunotherapy Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt.14.93/asset/images/medium/figure1.gif)
Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma | Immunotherapy
![Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial - The Lancet Haematology Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial - The Lancet Haematology](https://www.thelancet.com/cms/attachment/5f17591f-9f36-4294-95d2-a36ed404adb0/gr1_lrg.gif)